期刊文献+

大鼠脑内白细胞介素-1Ⅰ型受体在致痫活动中的表达变化 被引量:1

CHANGES OF TYPE Ⅰ INTERLEUKIN-1 RECEPTOR EXPRESSION IN BRAIN OF EPILEPTIC RATS
下载PDF
导出
摘要 为了探讨白细胞介素 -1I型受体 ( IL-1RI)在癫痫发病中的作用 ,本实验采用免疫组织化学方法观察了致痫大鼠行为改变与脑内 IL-1RI表达变化。结果发现 ,侧脑室注射白细胞介素 -1β( IL-1β)后再注射阈下剂量谷氨酸钠 ,可导致动物痫样发作 ,其大脑皮质及海马锥体细胞层 IL -1RI免疫反应阳性细胞数量较对照组明显增多 ,免疫反应增强 ;如先注射白细胞介素 1受体拮抗剂 ( IL-1ra)、再注射 IL-1β和阈下剂量谷氨酸钠 ,则动物无痫样发作 ,且大脑皮质及海马锥体细胞层 IL-1RI免疫反应阳性细胞数量较注射 IL -1β和阈下剂量谷氨酸钠组减少 ,免疫反应着色减弱。结果提示 ,IL -1β有明显促进谷氨酸钠致痫的作用 ,IL-1RI可能参与致痫过程 ,IL-1ra具有抗痫效应。 In order to investigate the effect of IL-1 RI in epilepsy, the expression changes of IL-1 RI in brain of epileptic rats were studied by immunohistochemical staining, and the behavior changes were observed.The results showed that there was epileptic seizure after injecting IL-1β and subthreshold dose of sodium glutamate into the lateral ventricle of rats, and the numbers of IL-1 RI immunoreactive(IR) positive cells in hippocampus and cerebral cortex were significantly increased compared with the control group. Whenever the IL-1ra was injected into the lateral ventricle before IL-1β and subthreshold dose of sodium glutamate, seizure was restrained and the numbers of IL-1 RI-IR positive cells in hippocampus and cerebral cortex were significantly decreased compared with the previous group. These data suggest that IL-1β can promote the effect of sodium glutamate to induce the epileptic seizure, IL-1 RI might play an important role in epileptogenesis, while IL-1ra can restrain the seizure.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2003年第4期419-422,共4页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金 ( No.3 0 170 484) 湖北省自然科学基金 ( No.2 0 0 1ABB14 2 )资助项目
关键词 大鼠 白细胞介素-1I型受体 致痫活动 表达 癫痫 interleukin-1 receptor Ⅰ, interleukin-1 beta, interleukin-1 receptor antagonist, epilepsy, rat
  • 相关文献

参考文献1

  • 1吴逊.神经病学-癫痫和发作性疾病[M].北京:人民军医出版社,2001.45-46.

共引文献2

同被引文献20

  • 1Boeckeler K, Adley K, Xu X, et al. The neuroprotective agent, valpro- ic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dietyostelium discoideum [ J ]. Eur J Cell Biol,2006,85 (9 - 10) : 1047 - 1057.
  • 2de Lanerolle NC,Kim JH,Williamson A,et al. A retrospective analy- sis of hippocampal pathology in human temporal lobe epilepsy: evi- dence for distinctive patient subcategories [ J ]. Epilepsy, 2003,44 (5) :677 -687.
  • 3Choi J, Nordli DR Jr, Alden TD, et al. Cellular injury and neuroin- flammation in children with chronic intractable epilepsy[ J]. J Neu- roinflammation, 2009,19 ( 6 ) : 38.
  • 4Ziegler G,Prinz V,Albrecht MW, et al. Mrp-$ and-14 mediate CNS injury in focal cerebral ischemia [ J ]. Biochim Biophys Acta, 2009, 1792(12) :1198 - 1204.
  • 5Engel S,Schluesener H,Mittelbronn M,et al. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14 [ J ]. Acta Neuropatho1,2000,100 ( 3 ) :313 - 322.
  • 6Floris S, van der Goes A, Killestein J, et al. Monocyte activation and disease activity in muhiple sclerosis. A longitudinal analysis of serum MRP8/14 levels[ J ]. J Neuroimmuno1,2004,148 ( 1-2 ) : 172 - 177.
  • 7Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high- mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures[J]. Nat Med,2010,16(4) :413 -419.
  • 8Muramatsu R, lkegaya Y, Matsuki N,et al. Early-life status epilepti- cus induces ectopic granule cells in adult mice dentate gyms [ J ]. Exp Neuro1,2008,211 ( 2 ) :503 - 510.
  • 9Boeckeler K,Adley K,Xu X,et al. The neuroproteetive agent, valp- roic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum [ J ]. Eur J Cell Biol,2006,85 (9 - 10 ) : 1047 - 1057.
  • 10Bumanglag AV, Sloviter RS. Minimal latency to hippocampal epilep-togenesis and clinical epilepsy after perforant pathway stimulation-in- duced status epilepticus in awake rats [ J ]. J Comp Neurol,2008, 510(6) :561 -580.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部